A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men

被引:8
作者
Beiraghdar, Fatemeh [1 ]
Einollahi, Behzad [1 ]
Ghadyani, Alireza [1 ]
Panahi, Yunes [1 ]
Hadjiakhoondi, Abbas [2 ,3 ]
Vazirian, Mahdi [2 ,3 ]
Salarytabar, Ali [4 ]
Darvishi, Behrad [5 ]
机构
[1] Baghiatallah Univ Med Sci, Nephrol & Urol Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Fac Pharm, Dept Pharmacognosy, Tehran, Iran
[3] Univ Tehran Med Sci, Fac Pharm, Med Plants Res Ctr, Tehran, Iran
[4] ACECR, Integrat Oncol Dept, Breast Canc Res Ctr, Tehran, Iran
[5] ACECR, Recombinant Prot Dept, Breast Canc Res Ctr, Tehran, Iran
关键词
IPSS score; quality of life; prostate volume; extant urine volume; URINARY-TRACT SYMPTOMS; CLINICAL-TRIAL; DEPRESSIVE SYMPTOMS; BETA-SITOSTEROL; 5-ALPHA-REDUCTASE; INFLAMMATION; DIHYDROTESTOSTERONE; DUTASTERIDE; INHIBITORS; EXTRACT;
D O I
10.1080/13880209.2017.1328445
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Context: As an alternative approach, administration of phytotherapeutic agents in management of benign prostate hyperplasia (BPH), is rapidly growing each day. Different authors have indicated effectiveness of Viola odorata L. (Violaceae), Echium amoenum Fisch. & C.A.Mey. (Boraginaceae) and Physalis alkekengi L. (Solanaceae) in treatment of BPH. However, none have reported the beneficial outcomes of the mixture yet. Objective: This study evaluates the therapeutical effects of V. odorata, E. amoenum and P. alkekengi mixture on symptomatic BPH patients. Materials and methods: Eighty six symptomatic BPH patients with International Prostate Symptom Score (IPSS) of more than 13 and prostate volume of more than 30 cm(3) were randomly allocated to receive a two-week course of placebo (control group) or 1 mL of mixed hydro-alcoholic solution of P. alkekengi, E. amoenum and V. odorata extracts (1.5, 1 and 1.5% respectively) (treatment group). Results: IPSS score of incomplete urination (42.3 +/- 2.04%), frequency of urination (20.08 +/- 1.02%), intermittency (40.78 +/- 2.16%), urgency (60.91 +/- 3.14%), weak stream (50.58 +/- 2.14%), straining (55.67 +/- 2.53%) and nocturia (40.14 +/- 1.89%) in treatment group were significantly decreased after treatment compare to placebo receiving group. Furthermore, the prostate volume (16.92 +/- 0.89%) and extant urine volume (28.12 +/- 1.36%) also significantly decreased in treatment group compared to control group. No significant side effects or abnormalities in biochemical tests and urinalysis were observed throughout the study. Discussion and conclusions: Based on results, mentioned mixture is safe and effective in improving life quality of patients suffering from BPH.
引用
收藏
页码:1800 / 1805
页数:6
相关论文
共 45 条
[1]   Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia [J].
Aaron, LaTayia ;
Franco, Omar E. ;
Hayward, Simon W. .
UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (03) :279-+
[2]  
Abolhassani Mohsen, 2004, Braz J Infect Dis, V8, P382, DOI 10.1590/S1413-86702004000500008
[3]  
Alivizatos G, 2008, AGING KIDNEY HLTH DI
[4]   Dihydrotestosterone and the prostate:: the scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia [J].
Andriole, G ;
Bruchovsky, N ;
Chung, LWK ;
Matsumoto, AM ;
Rittmaster, R ;
Roehrborn, C ;
Russell, D ;
Tindall, D .
JOURNAL OF UROLOGY, 2004, 172 (04) :1399-1403
[5]   Traditional medicinal plants of cold desert Ladakh - Used against kidney and urinary disorders [J].
Ballabh, Basant ;
Chaurasia, O. P. ;
Ahmed, Zakwan ;
Singh, Shashi Bala .
JOURNAL OF ETHNOPHARMACOLOGY, 2008, 118 (02) :331-339
[6]   RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL-TRIAL OF BETA-SITOSTEROL IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA [J].
BERGES, RR ;
WINDELER, J ;
TRAMPISCH, HJ ;
SENGE, T ;
AEIKENS, B ;
ALBRECHT, J ;
BECKER, C ;
BRUNDIG, P ;
DREYER, D ;
KALDEWEY, W ;
LATKA, H ;
REEK, A ;
SCHNEIDER, HJ ;
SCHOTER, P ;
SCHUMACHER, C .
LANCET, 1995, 345 (8964) :1529-1532
[7]   Correlation between benign prostatic hyperplasia and inflammation [J].
Bostanci, Yakup ;
Kazzazi, Amir ;
Momtahen, Shabnam ;
Laze, Juliana ;
Djavan, Bob .
CURRENT OPINION IN UROLOGY, 2013, 23 (01) :5-10
[8]   The Association of Lower Urinary Tract Symptoms, Depression and Suicidal Ideation: Data from the 2005-2006 and 2007-2008 National Health and Nutrition Examination Survey [J].
Breyer, Benjamin N. ;
Kenfield, Stacey A. ;
Blaschko, Sarah D. ;
Erickson, Bradley A. .
JOURNAL OF UROLOGY, 2014, 191 (05) :1333-1339
[9]  
Bullock Travis L, 2006, Expert Opin Emerg Drugs, V11, P111, DOI 10.1517/14728214.11.1.111
[10]  
Chinese Pharmacopoeia Committee, 2005, PHARM PEOPL REP CHIN, V1, P250